Raf inhibitor Regorafenib monohydrate, Purity ≥98%

Synonym: 1019206-88-2; Regorafenib monohydrate; Regorafenib hydrate; Regorafenib (monohydrate); Regorafenib hydrate [JAN]; BAY 73-4506 monohydrate; 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate; Raf inhibitor

MDL: MFCD17170366
CAS Number: 1019206-88-2
Compound CID: 24768591

Product Size

50 mg; 100 mg; 200 mg; 500 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Regorafenib monohydrate, soluble in DMSO and ethanol, blocks a MAPK/ERK signaling pathway.

Molecular Weight

500.83

Molecular Formula

C₂₁H₁₇ClF₄N₄O₄

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 93 mg/mL (185.68 mM); Ethanol: <1 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Regorafenib monohydrate can be studied for its effects on targeting multiple kinases involved in tumor growth and angiogenesis.

Storage

Store at -20ºC.